Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

S 8780Session 2025-2026

Requires certain kratom products to include a warning label

S8780

Underlined text would be added to current law. Struck-through text would be removed.

Skip to main content

New York State Assembly

Speaker Carl E. Heastie

  • Assembly Members
  • Legislative Info
  • Public Hearings
  • Speaker's Press
  • Assembly Reports
  • Committees & More
  • Bill Search Home
  • Laws
  • Legislative Calendar
  • Public Hearing Schedule
  • Assembly Calendars
  • Assembly Committee Agenda
Javascript must be enabled to properly view this page. Bill No.:  
     
  •  Summary 
  •  
  •  Actions 
  •  
  •  Committee&nbspVotes 
  •  
  •  Floor&nbspVotes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber&nbspVideo/Transcript 

S08780 Summary:

BILL NOS08780
 
SAME ASSAME AS A09443
 
SPONSORSKOUFIS
 
COSPNSR
 
MLTSPNSR
 
Amd ?398-g, Gen Bus L (as proposed in S.8285 & A.5852-A)
 
Requires certain kratom products to include a warning label with disclosures including, but not limited to, that kratom may be addictive and to keep it out of reach of children.
Go to top

S08780 Text:

STATE OF NEW YORK ________________________________________________________________________ 8780 IN SENATE January 8, 2026 ___________ Introduced by Sen. SKOUFIS -- read twice and ordered printed, and when printed to be committed to the Committee on Rules AN ACT to amend the general business law, in relation to regulating the sale of kratom products The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Section 398-g of the general business law, as added by a 2 chapter of the laws of 2025 amending the general business law relating 3 to regulating the sale of kratom products, as proposed in legislative 4 bills numbers S. 8285 and A. 5852-A, is amended to read as follows: 5 § 398-g. Kratom package labeling. 1. For the purposes of this section, 6 [the following terms shall have the following meanings: 7 (a)] "Kratom" means [both] any part of the plant Mitragyna speciosa, 8 [a tree native to Southeast Asia, and the products derived from its 9 leaves that are marketed as herbal supplements. 10 (b) "All natural" means a product that contains no artificial ingredi- 11 ents or added colors and is minimally processed.] whether growing or 12 not, and any compound, manufacture, salt, derivative, mixture, or prepa- 13 ration of such plant or synthesized or semi-synthesized preparations of 14 mitragynine or 7-hydroxymitragynine, their derivatives, salts, esters, 15 and isomers. 16 2. [On each package of any kratom product sold or delivered by a 17 manufacturer within this state on or after January first, two thousand 18 twenty-six, there shall be printed thereon or attached thereto a warning 19 of such product's lack of federal food and drug administration approval 20 and such kratom products' known side effects. Such warning shall be in 21 a font not less than twelve-point type and in a color in contrast with 22 the package containing such kratom product, and shall contain the 23 following statement: 24 "WARNING This product has not been approved by the FDA. Side effects 25 may include nausea, agitation, hallucinations, difficulty breathing, 26 liver damage, and death"] No person, firm, partnership, association, or 27 corporation shall manufacture, distribute, sell or offer for sale at 28 retail within the state any product containing kratom unless there is EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD09239-04-6 S. 8780 2 1 printed thereon such packaging or attached thereto a label disclosing 2 the following: 3 (a) the name and address for the place of business of the manufacturer 4 or distributor of the kratom product; 5 (b) the full list of ingredients in the kratom product; 6 (c) the following disclosures: 7 (i) that sale or distribution by individuals who are under twenty-one 8 years of age is prohibited under the public health law; 9 (ii) that use by individuals who are pregnant or breastfeeding is not 10 advised; 11 (iii) to consult a healthcare professional prior to use; 12 (iv) that kratom may be addictive; 13 (v) that kratom may interact with certain medications, drugs, and 14 controlled substances; 15 (vi) whether the product includes a semi-synthesized chemical or 16 compound or synthesized chemical or compound of kratom. For the purposes 17 of this subparagraph the term "semi-synthesized chemical or compound" 18 shall mean a chemical or compound contained in a kratom extract that has 19 been exposed to chemicals or processes that would confer a structural 20 change in the chemical or compound, such as oxidation, reduction, and 21 ring opening and closing, resulting in material that has been chemically 22 altered. For the purposes of this subparagraph the term "synthesized 23 chemical or compound" shall mean a chemical or compound of kratom that 24 has been created by chemical synthesis or biosynthetic means, including 25 fermentation, recombinant techniques, and enzymatic techniques, rather 26 than by traditional food preparation techniques such as heating or 27 extracting; and 28 (vii) quantitative declarations of the amount of mitragynine and the 29 amount of 7-hydroxymitragynine by part, weight or volume of the kratom 30 product; and 31 (d) the following statements, clearly and conspicuously: 32 (i) "These statements have not been evaluated by the food and drug 33 administration. This product is not intended to diagnose, treat, cure, 34 or prevent any disease."; and 35 (ii) "Keep out of reach of children." 36 3. [No kratom product shall be advertised as nor shall the packaging 37 of such kratom product suggest, state, or imply that such kratom product 38 is all natural. 39 4.] Any [manufacturer] person, firm, partnership, association, or 40 corporation in violation of this section shall be subject to a civil 41 penalty of not more than five hundred dollars for a first violation and 42 not more than one thousand dollars for a second or subsequent violation. 43 § 2. This act shall take effect on the same date and in the same 44 manner as a chapter of the laws of 2025 amending the general business 45 law relating to regulating the sale of kratom products, as proposed in 46 legislative bills numbers S. 8285 and A. 5852-A, takes effect. Go to top <link href="/styles/noscript_styles.css" rel="stylesheet"/> Sitemap Request Information Directions and Maps

Official text from the New York Legislature. Formatting has been adapted for reading on Ratifi.